We noticed that cell lines originating from ovarian and kidney cancer contributed the most to the Sen-Scoreglobal for these drug classes, as in ovarian cancer cell lines, high HSPD1 expression was significantly associated with sensitivity to 39% of DNA rep. The gene discussed is HSPD1; the disease is ovarian carcinoma.